In particular, gliomas harboring mutations in the isocitrate dehydrogenase gene frequently exhibit weak or absent fluorescence, which complicates the intraoperative identification of tumor margins and may limit surgical efficacy. The gene discussed is IDH3A; the disease is neoplasm.